Current Affairs Topics Archive
International Relations Economics Polity & Governance Environment & Ecology Science & Technology Internal Security Geography Social Issues Art & Culture Modern History

Trump’s uniform 15% tariff could benefit parts of Asia-Pacific: Moody’s


What Happened

  • Moody's Analytics published an assessment of Trump's 15% uniform tariff announced February 21, 2026, finding that it would benefit Asia-Pacific economies that previously faced steeper country-specific tariffs, while countries already at approximately 15% see minimal change.
  • China, Vietnam, Cambodia, Bangladesh, and Indonesia — which had faced US tariffs of 20-30%+ under IEEPA country-specific rates — would see improved market access under a uniform 15% rate.
  • Japan, South Korea, and Taiwan, whose exports already faced approximately 15% US tariffs, would face minimal disruption.
  • For India, the picture is mixed: the interim deal negotiated a specific 18% rate, so a uniform 15% is arithmetically lower — but the broader deal package (including Russia oil commitment linkage and GSP restoration) remains commercially uncertain after the Supreme Court's IEEPA ruling.
  • Moody's cautioned that even in the best-case scenario, "plenty of trade uncertainty and logistical mess" would persist, with firms potentially seeking compensation for tariffs already paid — a contentious and time-consuming process.

Static Topic Bridges

Moody's Analytics and Sovereign Credit Ratings — Relevance for UPSC

Moody's Analytics is the economic research arm of Moody's Corporation, distinct from Moody's Investors Service (the credit rating agency). Moody's Investors Service, along with Standard & Poor's (S&P) and Fitch, forms the "Big Three" global credit rating agencies that assess sovereign and corporate credit risk. India's current sovereign credit rating from Moody's Investors Service is Baa3 (investment grade, lowest rung) with a "positive" outlook as of 2024. These ratings influence India's cost of borrowing in international markets, foreign institutional investor flows, and the terms on which Indian entities can raise external commercial borrowings (ECBs). Moody's upgraded India from Ba1 (sub-investment grade/junk) to Baa3 in November 2017 — the first upgrade in 14 years.

  • Moody's Investors Service rating for India: Baa3 (lowest investment grade); outlook: Stable/Positive
  • Big Three rating agencies: Moody's, S&P (India: BBB-), Fitch (India: BBB-)
  • Baa3/BBB- significance: Lowest investment grade; one notch below = "junk" (sub-investment grade)
  • India upgrade history: Ba1 → Baa3 (November 2017); has remained at Baa3 since
  • Impact of rating: Determines eligibility for many international institutional funds that cannot hold sub-investment grade assets

Connection to this news: Moody's Analytics' tariff assessment carries weight because of the institutional credibility of the broader Moody's brand; markets and policymakers treat these assessments as authoritative forward-looking analysis.


Asia-Pacific Trade Architecture: RCEP, CPTPP, and US Influence

The Asia-Pacific trade landscape is shaped by two major regional frameworks that lack US participation. The Regional Comprehensive Economic Partnership (RCEP), which came into force in January 2022, covers 15 countries: ASEAN 10, China, Japan, South Korea, Australia, and New Zealand. India negotiated but ultimately withdrew from RCEP in November 2019, citing concerns about the potential influx of Chinese goods and the asymmetric market access offered to India. The Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP) covers 12 countries (Canada, Australia, Japan, Mexico, Vietnam, and others) — the US withdrew under Trump's first term (2017) and has not rejoined. The absence of an overarching US-Asia Pacific FTA creates the bilateral deal space that Trump's tariff regime is exploiting.

  • RCEP: 15 members (ASEAN 10 + China, Japan, South Korea, Australia, New Zealand); effective January 1, 2022; world's largest FTA by GDP coverage
  • India's RCEP withdrawal: November 2019; concerns: trade deficit with China, dairy/agriculture market access, services exclusions
  • CPTPP: 12 members; covers ~15% of global GDP; US withdrew January 2017 (Trump first term)
  • TPP original: 12 members including US; renamed CPTPP after US exit
  • India's FTA status: Has CEPA/FTAs with ASEAN, South Korea, Japan, UAE, Mauritius, SAFTA; negotiating with EU, UK, Canada, US
  • China's CPTPP bid: Applied to join CPTPP (September 2021); not yet admitted

Connection to this news: The US's 15% uniform tariff and bilateral deal approach (with India, UK, others) is partly a strategic effort to maintain US trade centrality in Asia-Pacific without a multilateral framework — a direct response to China's expanding RCEP dominance.


India's Export Competitiveness Under Shifting US Tariffs

India competes with Vietnam, Bangladesh, China, and Indonesia in key US export categories — textiles, apparel, leather goods, footwear, and electronics. The competitive dynamics shift significantly with tariff changes. At the peak of US-China trade tensions, India gained textile and footwear orders as buyers diversified away from China. With Vietnam growing rapidly and Bangladesh benefiting from GSP (duty-free under the US Generalised System of Preferences for LDCs — Bangladesh qualifies as a Least Developed Country), Indian exporters faced a structural tariff disadvantage. The interim trade deal (18% for India) narrowed this gap, but a 15% uniform tariff that applies equally to Vietnam (not an LDC) and Bangladesh (LDC, may retain separate preference) complicates the comparative advantage calculation.

  • India's top US exports: Pharmaceutical preparations, petroleum products, textiles and apparel, engineering goods, gems and jewellery
  • India's garment exports to US: ~$4.5-5 billion/year (FY25)
  • Bangladesh's LDC status: Exports to US under GSP/AGOA-equivalent preferences (duty-free on most garments); US LDC GSP gives Bangladesh advantage
  • Bangladesh's EU market: Duty-free under "Everything But Arms" (EBA) for LDCs
  • Vietnam's US tariff (pre-IEEPA): Already elevated due to trade surplus concerns; post-uniform 15%: moderate
  • India's pharma exports to US: ~$8-9 billion/year; face competitive challenge from US FDA inspections and supply chain concerns

Connection to this news: Moody's analysis highlights that the 15% uniform tariff is not just about the US-India relationship; it reshapes the entire competitive landscape for India's exporters relative to Asia-Pacific competitors, particularly in labour-intensive sectors.


Trade Uncertainty and Investment Decision-Making

Moody's Analytics' warning about "trade uncertainty and logistical mess" reflects the macroeconomic literature on how policy uncertainty — distinct from the actual tariff level — damages investment and trade. The "wait-and-see" effect means firms delay capital expenditure when trade policy is unpredictable. The "supply chain fragmentation" effect means firms spend on redesigning supply chains rather than productive investment. For India, which is trying to attract foreign direct investment (FDI) into manufacturing through PLI (Production Linked Incentive) schemes across 14 sectors, trade policy uncertainty in the US — India's largest export market — could slow FDI decisions by global companies considering India as a manufacturing hub.

  • PLI scheme: Production Linked Incentive; announced 2020-21 for 14 sectors including electronics, pharmaceuticals, textiles, auto, food processing
  • PLI total outlay: ~Rs 2 lakh crore over 5-7 years across all 14 sectors
  • India's target FDI: $100 billion+/year (FY25 actual: ~$70-75 billion)
  • Key FDI sectors targeted: Electronics (Apple/Foxconn), semiconductors, defence, pharmaceuticals
  • Trade uncertainty impact: IMF estimates 1% rise in trade policy uncertainty reduces investment by ~0.75% within a year
  • "China+1" strategy: Global companies diversifying manufacturing from China; India, Vietnam, Indonesia competing for these orders

Connection to this news: Moody's caution about lingering uncertainty is directly relevant to India's manufacturing investment ambitions — the commercial attractiveness of India as an export platform depends partly on predictable access to the US market, which the current tariff volatility undermines.

Key Facts & Data

  • 15% uniform US tariff: Announced February 21, 2026 (via Section 232 + Section 301)
  • Previous IEEPA rates: China 25%+; India 25%; Vietnam 20-25%; Japan/Korea/Taiwan ~15%
  • India's interim deal rate: 18% (February 7, 2026) — higher than 15% uniform rate
  • Moody's India sovereign rating: Baa3 (investment grade, lowest rung)
  • RCEP: 15 members; effective January 1, 2022; India withdrew November 2019
  • CPTPP: 12 members; US withdrew January 2017
  • India's garment exports to US: ~$4.5-5 billion/year
  • India's pharma exports to US: ~$8-9 billion/year
  • PLI scheme: 14 sectors; ~Rs 2 lakh crore total outlay
  • Bangladesh LDC GSP advantage: Duty-free on most garments to US
  • Trade uncertainty effect: 1% rise in uncertainty → ~0.75% investment decline (IMF estimate)